{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:30:57Z","timestamp":1790173857184,"version":"4.1.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,2]]},"abstract":"<jats:p>Pleomorphic mantle cell lymphoma (PMCL) can closely mimic diffuse large B-cell lymphoma (DLBCL) morphologically, and expression of CD5 and cyclin D1 is helpful for differential diagnosis. To date, no cases of CD5\/cyclin D1 double-negative PMCL have been reported. Four cases of B-cell lymphoma with an immunophenotype of CD5(\u2212) cyclin D1(\u2212) SOX11(+) and morphologic features compatible with DLBCL were included. Two were previously identified, and the other 2 were screened from 500 cases of B-cell lymphoma. We analyzed their clinicopathologic, immunophenotypic, genetic, and gene expression features. Cases of cyclin D1-positive PMCL, cyclin D1-negative PMCL, germinal center B-cell (GCB) DLBCL, and activated B cell (ABC) DLBCL were also studied for comparison. Similar to other PMCL cases, these 4 patients were mainly elderly male individuals with an aggressive clinical course. None of these tumors had detectable translocations involving <jats:italic toggle=\"yes\">CCND1<\/jats:italic>, <jats:italic toggle=\"yes\">CCND2<\/jats:italic>, <jats:italic toggle=\"yes\">CCND3<\/jats:italic>, <jats:italic toggle=\"yes\">CCNE1<\/jats:italic>, <jats:italic toggle=\"yes\">CCNE2<\/jats:italic>, <jats:italic toggle=\"yes\">MYC<\/jats:italic>, <jats:italic toggle=\"yes\">BCL2<\/jats:italic>, or <jats:italic toggle=\"yes\">BCL6<\/jats:italic>. The genome-wide copy number profile of these 4 cases was similar to that of cyclin D1-negative PMCL. None of these tumors had high expression of cyclin D1, cyclin D2, or cyclin D3. Similar to cyclin D1-negative PMCL, these cases had higher expression of cyclin E1 and cyclin E2 compared with cyclin D1-positive PMCL. The gene expression pattern of these tumors was also similar to that of cyclin D1-negative PMCL. Here we report for the first time 4 cases of CD5\/cyclin D1 double-negative PMCL. SOX11 positivity is useful to identify these rare tumors, and further genetic and gene expression analysis can be used to confirm the diagnosis.<\/jats:p>","DOI":"10.1097\/pas.0000000000001390","type":"journal-article","created":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T19:28:24Z","timestamp":1572895704000},"page":"232-240","source":"Crossref","is-referenced-by-count":6,"title":["Identification of CD5\/Cyclin D1 Double-negative Pleomorphic Mantle Cell Lymphoma"],"prefix":"10.1097","volume":"44","author":[{"given":"Wen-Yu","family":"Chuang","sequence":"first","affiliation":[{"name":"Department of Pathology"},{"name":"Graduate Institute of Clinical Medical Sciences, College of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Tsung","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Chi-Mei Medical Center"},{"name":"Department of Nursing, National Tainan Institute of Nursing, Tainan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Tsu","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Pathology, National Taiwan University Hospital, College of Medicine, National Taiwan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwo-Jyh","family":"Chang","sequence":"additional","affiliation":[{"name":"Graduate Institute of Clinical Medical Sciences, College of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Hematology and Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Ju","family":"Yeh","sequence":"additional","affiliation":[{"name":"Department of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shir-Hwa","family":"Ueng","sequence":"additional","affiliation":[{"name":"Department of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiao-Wen","family":"Kao","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Hematology and Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong-Hong","family":"Wang","sequence":"additional","affiliation":[{"name":"Tissue Bank"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Liang","family":"Wan","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging and Intervention, Chang Gung Memorial Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee-Yung","family":"Shih","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Hematology and Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Sung","family":"Chuang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Chi-Mei Medical Center"},{"name":"Department of Pathology, School of Medicine, Taipei Medical University and National Taiwan University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuen","family":"Hsueh","sequence":"additional","affiliation":[{"name":"Department of Pathology"},{"name":"Tissue Bank"},{"name":"Chang Gung Molecular Medicine Research Center, Chang Gung University, Taoyuan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,10,29]]},"reference":[{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1309\/TE56-A43X-29TT-5H8G","article-title":"CD5\u2212 mantle cell lymphoma","volume":"118","author":"Liu","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/his.13161","article-title":"Pleomorphic mantle cell lymphoma morphologically mimicking diffuse large B cell lymphoma: common cyclin D1 negativity and a simple immunohistochemical algorithm to avoid the diagnostic pitfall","volume":"70","author":"Chuang","year":"2017","journal-title":"Histopathology"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1182\/blood-2005-04-1753","article-title":"Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling","volume":"106","author":"Fu","year":"2005","journal-title":"Blood"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1182\/blood-2018-07-862151","article-title":"CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1(\u2212) mantle cell lymphoma","volume":"133","author":"Martin-Garcia","year":"2019","journal-title":"Blood"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/ncomms1008","article-title":"Organogenesis relies on SoxC transcription factors for the survival of neural and mesenchymal progenitors","volume":"1","author":"Bhattaram","year":"2010","journal-title":"Nat Commun"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3324\/haematol.2009.010264","article-title":"SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype","volume":"94","author":"Mozos","year":"2009","journal-title":"Haematologica"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/PAS.0b013e318241f050","article-title":"Cyclin D1-negative blastoid mantle cell lymphoma identified by SOX11 expression","volume":"36","author":"Zeng","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"5494","DOI":"10.1158\/1078-0432.CCR-09-0113","article-title":"A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy","volume":"15","author":"Choi","year":"2009","journal-title":"Clin Cancer Res"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1200\/JCO.2011.41.0985","article-title":"Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone","volume":"30","author":"Johnson","year":"2012","journal-title":"J Clin Oncol"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00428-015-1845-1","article-title":"CD5 positivity is an independent adverse prognostic factor in elderly patients with diffuse large B cell lymphoma","volume":"467","author":"Chuang","year":"2015","journal-title":"Virchows Arch"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1182\/blood-2013-11-536433","article-title":"Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue","volume":"123","author":"Scott","year":"2014","journal-title":"Blood"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"W147","DOI":"10.1093\/nar\/gkw419","article-title":"Heatmapper: web-enabled heat mapping for all","volume":"44","author":"Babicki","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1097\/PAI.0000000000000067","article-title":"Utility and diagnostic pitfalls of SOX11 monoclonal antibodies in mantle cell lymphoma and other lymphoproliferative disorders","volume":"22","author":"Nakashima","year":"2014","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1038\/leu.2009.144","article-title":"Gene knockdown studies revealed CCDC50 as a candidate gene in mantle cell lymphoma and chronic lymphocytic leukemia","volume":"23","author":"Farfsing","year":"2009","journal-title":"Leukemia"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"5724","DOI":"10.1158\/1078-0432.CCR-08-3215","article-title":"Phosphatidylinositol 3\u2032-kinase catalytic subunit alpha gene amplification contributes to the pathogenesis of mantle cell lymphoma","volume":"15","author":"Psyrri","year":"2009","journal-title":"Clin Cancer Res"},{"key":"R21-20230922","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/modpathol.2009.140","article-title":"Nuclear expression of sox11 is highly associated with mantle cell lymphoma but is independent of t(11;14)(q13;q32) in non-mantle cell B-cell neoplasms","volume":"23","author":"Chen","year":"2010","journal-title":"Mod Pathol"},{"key":"R22-20230922","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.critrevonc.2017.03.020","article-title":"Lymphoblastic lymphoma","volume":"113","author":"Cortelazzo","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"key":"R25-20230922","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/PAS.0b013e3182a43996","article-title":"Assessment of SOX11 expression in routine lymphoma tissue sections: characterization of new monoclonal antibodies for diagnosis of mantle cell lymphoma","volume":"38","author":"Soldini","year":"2014","journal-title":"Am J Surg Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001390","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T22:56:14Z","timestamp":1695423374000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001390"}},"subtitle":["A Clinicopathologic, Genetic, and Gene Expression Study"],"short-title":[],"issued":{"date-parts":[[2019,10,29]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001390","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10,29]]}}}